{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T17:19:23Z","timestamp":1792343963788,"version":"4.4.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100016230","name":"Steven and Alexandra Cohen Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016230","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["General Hospital Psychiatry"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.genhosppsych.2025.12.021","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T16:55:11Z","timestamp":1767027311000},"page":"30-40","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Psychological support can be distinguished from psychotherapy: Clarifications for future empirical work"],"prefix":"10.1016","volume":"99","author":[{"given":"Jonathan R.","family":"Schettino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep M.","family":"Nayak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon M.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Yaden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.genhosppsych.2025.12.021_bb0015","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1001\/jamapsychiatry.2022.2096","article-title":"Percentage of heavy drinking days following psilocybin-assisted psychotherapy vs placebo in the treatment of adult patients with alcohol use disorder: a randomized clinical trial","volume":"79","author":"Bogenschutz","year":"2022","journal-title":"JAMA Psychiatry"},{"issue":"5","key":"10.1016\/j.genhosppsych.2025.12.021_bb0025","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/jamapsychiatry.2020.3285","article-title":"Effects of psilocybin-assisted therapy on major depressive disorder: a randomized clinical trial","volume":"78","author":"Davis","year":"2021","journal-title":"JAMA Psychiatry"},{"issue":"9","key":"10.1016\/j.genhosppsych.2025.12.021_bb0135","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1001\/jama.2023.14530","article-title":"Single-dose psilocybin treatment for major depressive disorder: a randomized clinical trial","volume":"330","author":"Raison","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.genhosppsych.2025.12.021_bb0145","article-title":"Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial","volume":"56","author":"von Rotz","year":"2023","journal-title":"EClinicalMedicine"},{"issue":"4","key":"10.1016\/j.genhosppsych.2025.12.021_bb0085","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1176\/appi.psychotherapy.20200055","article-title":"Systematized review of psychotherapeutic components of psilocybin-assisted psychotherapy","volume":"74","author":"Horton","year":"2021","journal-title":"Am J Psychother"},{"issue":"4","key":"10.1016\/j.genhosppsych.2025.12.021_bb0105","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1080\/02791072.2020.1769878","article-title":"A meta-analysis of placebo-controlled trials of psychedelic-assisted therapy","volume":"52","author":"Luoma","year":"2020","journal-title":"J Psychoactive Drugs"},{"issue":"4","key":"10.1016\/j.genhosppsych.2025.12.021_bb0020","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1089\/psymed.2023.0007","article-title":"A systematic review of reporting practices in psychedelic clinical trials: psychological support, therapy, and psychosocial interventions","volume":"1","author":"Brennan","year":"2023","journal-title":"Psychedelic Medi"},{"issue":"5","key":"10.1016\/j.genhosppsych.2025.12.021_bb0110","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1001\/jamapsychiatry.2023.0099","article-title":"Studying harms is key to improving psychedelic-assisted therapy\u2014participants call for changes to research landscape","volume":"80","author":"McNamee","year":"2023","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"10.1016\/j.genhosppsych.2025.12.021_bb0155","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S2215-0366(24)00333-X","article-title":"Quality of reporting on psychological interventions in psychedelic treatments: a systematic review","volume":"12","author":"Seybert","year":"2025","journal-title":"Lancet Psychiatry"},{"issue":"1","key":"10.1016\/j.genhosppsych.2025.12.021_bb0060","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1176\/appi.ajp.20221043","article-title":"Must psilocybin always \u201cassist psychotherapy\u201d?","volume":"181","author":"Goodwin","year":"2024","journal-title":"Am J Psychiatry"},{"issue":"1","key":"10.1016\/j.genhosppsych.2025.12.021_bb0065","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1176\/appi.ajp.20230905","article-title":"Psychological support for psilocybin treatment: reply to letters on our commentary","volume":"181","author":"Goodwin","year":"2024","journal-title":"Am J Psychiatry"},{"issue":"1","key":"10.1016\/j.genhosppsych.2025.12.021_bb0005","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1176\/appi.ajp.20230665","article-title":"Psychotherapy in psychedelic treatment: safe, evidence-based, and necessary","volume":"181","author":"Alpert","year":"2024","journal-title":"Am J Psychiatry"},{"issue":"1","key":"10.1016\/j.genhosppsych.2025.12.021_bb0010","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1176\/appi.ajp.20230643","article-title":"Pharmacological and nonpharmacological components of psychedelic treatments: the whole is not the sum of the parts","volume":"181","author":"Bogenschutz","year":"2024","journal-title":"Am J Psychiatry"},{"issue":"1","key":"10.1016\/j.genhosppsych.2025.12.021_bb0030","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1176\/appi.ajp.20230667","article-title":"\u201cPsychedelic assisted therapy\u201d must not be retired","volume":"181","author":"Deckel","year":"2024","journal-title":"Am J Psychiatry"},{"issue":"1","key":"10.1016\/j.genhosppsych.2025.12.021_bb0040","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1176\/appi.ajp.20230661","article-title":"Misinterpretations and omissions: a critical response to Goodwin and colleagues\u2019 commentary on psilocybin-assisted therapy","volume":"181","author":"O\u2019Donnell","year":"2024","journal-title":"Am J Psychiatry"},{"issue":"1","key":"10.1016\/j.genhosppsych.2025.12.021_bb0045","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1176\/appi.ajp.20230572","article-title":"Psilocybin without psychotherapy: a cart without a horse?","volume":"181","author":"Earleywine","year":"2024","journal-title":"Am J Psychiatry"},{"issue":"1","key":"10.1016\/j.genhosppsych.2025.12.021_bb0150","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1176\/appi.ajp.20230664","article-title":"Is poorly assisted psilocybin treatment an increasing risk?","volume":"181","author":"Schenberg","year":"2024","journal-title":"Am J Psychiatry"},{"issue":"6","key":"10.1016\/j.genhosppsych.2025.12.021_bb0115","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/s41591-021-01336-3","article-title":"MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study","volume":"27","author":"Mitchell","year":"2021","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.genhosppsych.2025.12.021_bb0160","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41398-020-00897-0","article-title":"A randomized, double-blind, active placebo-controlled study of efficacy, safety, and durability of repeated vs single subanesthetic ketamine for treatment-resistant depression","volume":"10","author":"Shiroma","year":"2020","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.genhosppsych.2025.12.021_bb0090","series-title":"Intentional interviewing & counseling: Facilitating client development in a multicultural world. Belmont","author":"Ivey","year":"2010"},{"key":"10.1016\/j.genhosppsych.2025.12.021_bb0140","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1089\/psymed.2024.0026","article-title":"What is psychological support in the context of psychedelic clinical trials?","volume":"3","author":"Richard","year":"2025","journal-title":"Psychedelic Medi"},{"issue":"6","key":"10.1016\/j.genhosppsych.2025.12.021_bb0070","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1080\/17512433.2020.1772054","article-title":"Integrating psychotherapy and psychopharmacology: psychedelic-assisted psychotherapy and other combined treatments","volume":"13","author":"Greenway","year":"2020","journal-title":"Expert Rev Clinl Pharmacol"},{"key":"10.1016\/j.genhosppsych.2025.12.021_bb0130","series-title":"What is psychotherapy? Contemporary perspectives","first-page":"218","article-title":"An eclectic definition of psychotherapy","author":"Norcross","year":"1990"},{"key":"10.1016\/j.genhosppsych.2025.12.021_bb0050","author":"European Association for Psychotherapy (EAP)"},{"key":"10.1016\/j.genhosppsych.2025.12.021_bb0055","series-title":"Persuasion and healing: A comparative study of psychotherapy","author":"Frank","year":"1993"},{"issue":"5","key":"10.1016\/j.genhosppsych.2025.12.021_bb0075","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1177\/1363461520983684","article-title":"Psychedelics, placebo effects, and set and setting: insights from common factors theory of psychotherapy","volume":"59","author":"Gukasyan","year":"2022","journal-title":"Transcult Psychiatry"},{"issue":"4","key":"10.1016\/j.genhosppsych.2025.12.021_bb0125","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1055\/a-1312-7297","article-title":"Psychedelics and psychotherapy","volume":"54","author":"Nayak","year":"2021","journal-title":"Pharmacopsychiatry"},{"issue":"3","key":"10.1016\/j.genhosppsych.2025.12.021_bb0165","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/wps.20238","article-title":"How important are the common factors in psychotherapy? An update","volume":"14","author":"Wampold","year":"2015","journal-title":"World Psychiatry"},{"issue":"12","key":"10.1016\/j.genhosppsych.2025.12.021_bb0080","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1001\/jamapsychiatry.2024.2546","article-title":"Adverse events in studies of classic psychedelics: a systematic review and meta-analysis","volume":"81","author":"Hinkle","year":"2024","journal-title":"JAMA Psychiatry"},{"issue":"103692","key":"10.1016\/j.genhosppsych.2025.12.021_bb0120","first-page":"1","article-title":"Investigational psilocybin treatment for post-traumatic stress disorder: a qualitative study of participant experience, trauma engagement, and differences from standard treatment","volume":"90","author":"Modlin","year":"2025","journal-title":"EClinicalMedicine"},{"issue":"1","key":"10.1016\/j.genhosppsych.2025.12.021_bb0035","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1741-7015-7-79","article-title":"Psychoeducation for depression, anxiety and psychological distress: a meta-analysis","volume":"7","author":"Donker","year":"2009","journal-title":"BMC Med"},{"issue":"7","key":"10.1016\/j.genhosppsych.2025.12.021_bib166","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S2215-0366(16)30065-7","article-title":"Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study","volume":"3","author":"Carhart-Harris","year":"2016","journal-title":"The Lancet Psychiatry"},{"issue":"15","key":"10.1016\/j.genhosppsych.2025.12.021_bib167","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1056\/NEJMoa2032994","article-title":"Trial of psilocybin versus escitalopram for depression","volume":"384","author":"Carhart-Harris","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.genhosppsych.2025.12.021_bb0100","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2307\/2529310","article-title":"The measurement of observer agreement for categorical data","author":"Landis","year":"1977","journal-title":"Biometrics"},{"issue":"1","key":"10.1016\/j.genhosppsych.2025.12.021_bb0095","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1176\/appi.ajp.20230884","article-title":"Compass psychological support model for COMP360 psilocybin treatment of serious mental health conditions","volume":"182","author":"Kirli\u0107","year":"2025","journal-title":"Am J Psychiatry"}],"updated-by":[{"DOI":"10.1016\/j.genhosppsych.2026.05.005","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000}}],"container-title":["General Hospital Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163834325002506?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163834325002506?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T20:02:10Z","timestamp":1780862530000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163834325002506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":35,"alternative-id":["S0163834325002506"],"URL":"https:\/\/doi.org\/10.1016\/j.genhosppsych.2025.12.021","relation":{},"ISSN":["0163-8343"],"issn-type":[{"value":"0163-8343","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Psychological support can be distinguished from psychotherapy: Clarifications for future empirical work","name":"articletitle","label":"Article Title"},{"value":"General Hospital Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.genhosppsych.2025.12.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}